Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Pharm Res. 2013 Dec 3;31(4):1046–1058. doi: 10.1007/s11095-013-1226-x

Fig. 3.

Fig. 3

(a) Fluorescence intensity vs. concentration of Alexa647, dsRNA, pRNA-3WJ, and pRNA-X in PBS in vials. (b to e) Mean fluorescence intensities at the eyes (diamonds) and the cervical lymph nodes (squares) after subconjunctival injection. (b) Alexa647; (c) dsRNA; (d) pRNA-3WJ; (e) pRNA-X. The background fluorescence levels at the eyes (solid lines) and lymph nodes (dotted lines) were obtained from animals without the injection (control). Individual data points obtained from three animals are presented in each plot.